What question did this study set out to answer?

To create a prognostic model by analyzing glycine, serine, and threonine metabolism in endometrial cancer.

March 2, 2026Open Access

Integrative Analysis of Glycine, Serine, and Threonine Metabolism and the Immune Microenvironment in Endometrial Cancer: A Prognostic Model and Metabolic-Immune Framework for Precision Oncology

Key Points

To create a prognostic model by analyzing glycine, serine, and threonine metabolism in endometrial cancer.
Identified biomarkers MTHFD2, RPS6KA1, and CDKN2A through metabolic analysis.
Developed a patient stratification framework based on the biomarker expression.
Integrated metabolic and immune environment data for analysis.
The model shows significant potential in predicting clinical outcomes for endometrial cancer.
Expression levels of identified biomarkers correlate with disease progression.

Abstract

This study developed a Gly/Ser/Thr pathway-based prognostic model for EC, based on the expression of MTHFD2, RPS6KA1, and CDKN2A as novel biomarkers. The resulting patient stratification framework holds significant clinical potential for guiding precise and personalized management of EC.

Bookmark

View Full Paper

Cite This Study

Ye et al. (Wed,) studied this question.

synapsesocial.com/papers/69a52e64f1e85e5c73bf218c https://doi.org/https://doi.org/10.31083/fbl48779

Bookmark

View Full Paper